PI3K(p110α) Inhibitors as Anti-Cancer Agents: Minding the Heart

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cell Cycle

• Publication date

  2007-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4161/cc.6.8.4124
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Protective effects of exercise and phosphoinositide 3-kinase(p110α) signaling in dilated and hypertrophic cardiomyopathy

  2007cited by this paper
• DIFFERENCES BETWEEN PATHOLOGICAL AND PHYSIOLOGICAL CARDIAC HYPERTROPHY: NOVEL THERAPEUTIC STRATEGIES TO TREAT HEART FAILURE

  2007cited by this paper
• Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis

  2006cited by this paper
• Handicapping the Race to Develop Inhibitors of the Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway

  2006cited by this paper
• Prevention of High-Dose Chemotherapy-Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition

  2006cited by this paper
• Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation

  2006cited by this paper
• Myostatin Regulates Cardiomyocyte Growth Through Modulation of Akt Signaling

  2006cited by this paper
• Cardiotoxicity of the cancer therapeutic agent imatinib mesylate

  2006cited by this paper
• Akt2 Regulates Cardiac Metabolism and Cardiomyocyte Survival*

  2006cited by this paper
• Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

  2006cited by this paper
• Akt1 Is Required for Physiological Cardiac Growth

  2006cited by this paper
• PI 3-Kinases: Hidden Potentials Revealed

  2006cited by this paper
• Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase.

  2006cited by this paper
• Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis

  2006cited by this paper
• A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma.

  2006cited by this paper
• Signalling by PI3K isoforms: insights from gene-targeted mice.

  2005cited by this paper
• ABL oncogenes and phosphoinositide 3-kinase: mechanism of activation and downstream effectors.

  2005cited by this paper
• Mutated PI 3-Kinases: Cancer Targets on a Silver Platter

  2005cited by this paper
• Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex

  2005cited by this paper
• Telomerase RNA Mutated in Autosomal Dyskeratosis Congenita Reconstitutes a Weakly Active Telomerase Enzyme Defective in Telomere Elongation

  2005cited by this paper
• Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies.

  2004cited by this paper
• Inhibition of mTOR Signaling With Rapamycin Regresses Established Cardiac Hypertrophy Induced by Pressure Overload

  2004cited by this paper
• Mutation of the PIK3CA Gene in Ovarian and Breast Cancer

  2004cited by this paper
• The Insulin-like Growth Factor 1 Receptor Induces Physiological Heart Growth via the Phosphoinositide 3-Kinase(p110α) Pathway*

  2004cited by this paper
• Clinical cardiac tolerability of trastuzumab.

  2004cited by this paper
• High Frequency of Mutations of the PIK3CA Gene in Human Cancers

  2004cited by this paper
• Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy

  2003cited by this paper
• ErbB2 is essential in the prevention of dilated cardiomyopathy

  2002cited by this paper
• Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action.

  2002cited by this paper
• The conserved phosphoinositide 3‐kinase pathway determines heart size in mice

  2000cited by this paper
• A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.

  1998cited by this paper
• Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates.

  1997cited by this paper
• Impact of different sports and training on cardiac structure and function.

  1997cited by this paper
• Transgenic Gαq overexpression induces cardiac contractile failure in mice

  1997cited by this paper
• PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

  1997cited by this paper
• Transgenic Galphaq overexpression induces cardiac contractile failure in mice.

  1997cited by this paper
• Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research.

  1997cited by this paper
• Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

  1997cited by this paper
• Signalling through the lipid products of phosphoinositide-3-OH kinase

  1997cited by this paper
• Phosphoinositide 3-kinases: a conserved family of signal transducers.

  1997cited by this paper
• Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

  1990cited by this paper

• Reduced PI3K(p110α) induces atrial myopathy, and PI3K-related lipids are dysregulated in athletes with atrial fibrillation

  2025cites this paper
• Cardiomyocyte Atrophy, an Underestimated Contributor in Doxorubicin-Induced Cardiotoxicity

  2022cites this paper
• PI3K inhibitors in thrombosis and cardiovascular disease

  2020cites this paper
• For Better or Worse: The Potential for Dose Limiting the On-Target Toxicity of PI 3-Kinase Inhibitors

  2019cites this paper
• Gene delivery of medium chain acyl-coenzyme A dehydrogenase induces physiological cardiac hypertrophy and protects against pathological remodelling.

  2018cites this paper
• The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and Protection.

  2017cites this paper
• Enhancement of tumor cell susceptibility to natural killer cell activity through inhibition of the PI3K signaling pathway

  2016cites this paper
• Vascular and Metabolic Implications of Novel Targeted Cancer Therapies: Focus on Kinase Inhibitors.

  2015cites this paper
• Molecular basis of cancer-therapy-induced cardiotoxicity: introducing microRNA biomarkers for early assessment of subclinical myocardial injury.

  2014cites this paper
• Role of preeclampsia-related angiogenic factors in sunitinib cardiotoxicity: two cases and review of the literature.

  2013cites this paper
• Lipid-mediated Protein Signaling

  2013cites this paper
• Role of phosphatidylinositol 3,4,5-trisphosphate in cell signaling.

  2013cites this paper
• Phosphoinositide 3-Kinase p110&agr; Is a Master Regulator of Exercise-Induced Cardioprotection and PI3K Gene Therapy Rescues Cardiac Dysfunction

  2012cites this paper
• Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes

  2012cites this paper
• The yin and yang of adaptive and maladaptive processes in heart failure

  2012cites this paper
• Phosphoinositide 3-Kinase (PI3K(p110α)) Directly Regulates Key Components of the Z-disc and Cardiac Structure*

  2011cites this paper
• Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes

  2011cites this paper
• The PKB/AKT pathway in cancer.

  2010cites this paper
• Why do kinase inhibitors cause cardiotoxicity and what can be done about it?

  2010cites this paper
• Molecular mechanisms of cardiovascular toxicity of targeted cancer therapeutics.

  2010cites this paper
• Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies.

  2010cites this paper
• PI3K(p110&agr;) Protects Against Myocardial Infarction-Induced Heart Failure: Identification of PI3K-Regulated miRNA and mRNA

  2010cites this paper
• Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation.

  2009cites this paper
• The protective effects of exercise and phosphoinositide 3-kinase (p110alpha) in the failing heart.

  2009cites this paper
• Insulin signaling pathways and cardiac growth.

  2008cites this paper
• Molecular Drug Targets

  2008cites this paper
• Drugs and their molecular targets: an updated overview

  2008cites this paper
• ROLE OF INSULIN‐LIKE GROWTH FACTOR 1 AND PHOSPHOINOSITIDE 3‐KINASE IN A SETTING OF HEART DISEASE

  2008cites this paper
• Avian and 1918 Spanish Influenza A Virus NS1 Proteins Bind to Crk/CrkL Src Homology 3 Domains to Activate Host Cell Signaling*

  2008cites this paper
• PIK3CA gene amplification in Japanese non-small cell lung cancer.

  2007cites this paper